BUY MBP ABACAVIR SULPHATE & LAMIVUDINE TABLETS ALBAVIR 30TAB BEST PRICE ONLINE IN NIGERIA LAGOS ABUJA KANO AND PORTHARCOURT AT MYBIGPHARMACY.COM

Description

Dear friend, this medication requires a prescription or medical license before it can be delivered to you. kindly ensure that you provide us with a reliable contact information at checkout, mybigpharmacy team will be in touch with you to obtain required document before your order is confirmed thank you for trusting mybig pharmacy with your health. Abacavir sulphate and lamivudine tablets are a combination antiretroviral medicine used to treat infection with the human immunodeficiency virus, commonly known as HIV. This combination contains two medicines that belong to a group called nucleoside reverse transcriptase inhibitors. These medicines work together to stop the HIV virus from multiplying in the body, helping to control the infection, protect the immune system, and reduce the risk of HIV-related illness.

Abacavir sulphate and lamivudine do not cure HIV, but they help lower the amount of virus in the blood, known as the viral load, and increase the number of CD4 cells, which are important immune cells that fight infection. When taken correctly and consistently, this treatment helps people living with HIV stay healthy and reduces the risk of transmitting the virus to others. This medicine is always used as part of combination antiretroviral therapy and not alone.

Abacavir works by blocking an enzyme called reverse transcriptase, which HIV needs to replicate and spread in the body. Lamivudine works in a similar way, and together they provide stronger and more effective viral suppression than either drug alone. Using both medicines together also reduces the risk of the virus becoming resistant to treatment.

Abacavir sulphate and lamivudine tablets are usually taken once or twice daily depending on the prescribed regimen. They can be taken with or without food. It is important to take the medicine at the same time every day to maintain steady drug levels in the blood. Missing doses can allow the virus to multiply and may lead to treatment failure or resistance.

Before starting abacavir, patients must be tested for a genetic marker called HLA-B*5701. People who carry this gene are at high risk of developing a serious and potentially life-threatening allergic reaction to abacavir. If the test is positive, abacavir must never be used. If the test is negative, the medicine can be started, but patients must still be monitored closely.

A serious hypersensitivity reaction can occur with abacavir, usually within the first six weeks of treatment. Symptoms may include fever, rash, nausea, vomiting, diarrhoea, abdominal pain, tiredness, cough, shortness of breath, or general flu-like symptoms. If these symptoms occur, the medicine must be stopped immediately and medical attention sought. Abacavir must never be restarted after a suspected hypersensitivity reaction, as this can be life-threatening.

Common side effects of abacavir and lamivudine include headache, nausea, vomiting, diarrhoea, tiredness, and difficulty sleeping. These side effects are usually mild and improve over time. Less commonly, patients may experience changes in liver enzymes, muscle pain, or changes in body fat distribution with long-term treatment.

Lamivudine is also active against hepatitis B virus. In patients who have both HIV and hepatitis B, stopping lamivudine suddenly can cause a flare-up or worsening of hepatitis. Therefore, liver function should be monitored closely, and treatment changes should always be supervised by a healthcare professional.

Abacavir sulphate and lamivudine are generally well tolerated and suitable for long-term use when taken correctly. Regular monitoring includes viral load testing, CD4 counts, liver and kidney function tests, and general health assessments. These checks help ensure the medicine continues to work effectively and safely.

Patients taking this combination should inform their healthcare provider about all other medicines they are using, including herbal products and supplements, as drug interactions can occur. Alcohol intake should be moderate, especially in people with liver disease.

This medication does not prevent the transmission of other sexually transmitted infections, so protective measures such as condom use are still recommended. It also does not cure HIV, but with consistent daily use, it allows people living with HIV to lead long, healthy, and productive lives.

In summary, abacavir sulphate and lamivudine tablets are an effective and widely used treatment for HIV infection. When taken correctly and with regular medical follow-up, they help control the virus, strengthen the immune system, and significantly improve long-term health outcomes.